Cancer Drugs Should Cost Less, Say Doctors
Doctors argue that some drug companies are charging too much for their cancer drugs, to the detriment of patients.
Contributors
Susan Young
Follow @twitterapiBiomedicine Editor
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
Type
Bird Flu: On the Move and Hard to Track
The H7N9 virus is deadly to humans but does not present symptoms in birds, which makes it more difficult to control.
Questions over Gene Patents Shake Diagnostics Industry
The impending Supreme Court ruling on gene patents is creating uncertainty in the molecular diagnostics sector.
Multifunctional Drugs May Offer Better-Than-Additive Effects
A startup called Catabasis is developing drugs that hit diseases at multiple targets.
Samsung Demos a Tablet Controlled by Your Brain
An easy-to-use EEG cap could expand the number of ways to interact with your mobile devices.
uBiome Will Catalog Your Microbes, Again and Again
Your genome may not change, but your microbiome will.
A Decade of Advances Since the Human Genome Project
Despite breakthroughs in technology and medicine, there's still a lot of work ahead for understanding and using the human genome.
Wireless Micro LEDs Control Mouse Behavior
Mice tap into their own neural reward circuits with the help of a new optogenetics device.
